488 related articles for article (PubMed ID: 23792088)
1. Pathophysiology-based novel pharmacotherapy for heart failure with preserved ejection fraction.
Konstantinou DM; Chatzizisis YS; Giannoglou GD
Pharmacol Ther; 2013 Nov; 140(2):156-66. PubMed ID: 23792088
[TBL] [Abstract][Full Text] [Related]
2. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
3. Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.
From AM; Borlaug BA
Cardiovasc Ther; 2011 Aug; 29(4):e6-21. PubMed ID: 20370792
[TBL] [Abstract][Full Text] [Related]
4. Heart failure with preserved ejection fraction: a clinical dilemma.
Komajda M; Lam CS
Eur Heart J; 2014 Apr; 35(16):1022-32. PubMed ID: 24618346
[TBL] [Abstract][Full Text] [Related]
5. Role of oxidants on calcium and sodium movement in healthy and diseased cardiac myocytes.
Sag CM; Wagner S; Maier LS
Free Radic Biol Med; 2013 Oct; 63():338-49. PubMed ID: 23732518
[TBL] [Abstract][Full Text] [Related]
6. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
Kontogeorgos S; Thunström E; Johansson MC; Fu M
Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
[TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin-aldosterone system inhibitors in heart failure.
Shearer F; Lang CC; Struthers AD
Clin Pharmacol Ther; 2013 Oct; 94(4):459-67. PubMed ID: 23852393
[TBL] [Abstract][Full Text] [Related]
8. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).
Maeder MT; Rickenbacher P; Rickli H; Abbühl H; Gutmann M; Erne P; Vuilliomenet A; Peter M; Pfisterer M; Brunner-La Rocca HP;
Eur J Heart Fail; 2013 Oct; 15(10):1148-56. PubMed ID: 23657728
[TBL] [Abstract][Full Text] [Related]
9. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
Solomon SD; Rizkala AR; Lefkowitz MP; Shi VC; Gong J; Anavekar N; Anker SD; Arango JL; Arenas JL; Atar D; Ben-Gal T; Boytsov SA; Chen CH; Chopra VK; Cleland J; Comin-Colet J; Duengen HD; Echeverría Correa LE; Filippatos G; Flammer AJ; Galinier M; Godoy A; Goncalvesova E; Janssens S; Katova T; Køber L; Lelonek M; Linssen G; Lund LH; O'Meara E; Merkely B; Milicic D; Oh BH; Perrone SV; Ranjith N; Saito Y; Saraiva JF; Shah S; Seferovic PM; Senni M; Sibulo AS; Sim D; Sweitzer NK; Taurio J; Vinereanu D; Vrtovec B; Widimský J; Yilmaz MB; Zhou J; Zweiker R; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; McMurray JJV
Circ Heart Fail; 2018 Jul; 11(7):e004962. PubMed ID: 29980595
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
[TBL] [Abstract][Full Text] [Related]
11. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.
Lund LH; Benson L; Dahlström U; Edner M
JAMA; 2012 Nov; 308(20):2108-17. PubMed ID: 23188027
[TBL] [Abstract][Full Text] [Related]
12. Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data.
Beldhuis IE; Streng KW; Ter Maaten JM; Voors AA; van der Meer P; Rossignol P; McMurray JJ; Damman K
Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28209765
[TBL] [Abstract][Full Text] [Related]
13. Combination Therapy of Renin Angiotensin System Inhibitors and β-Blockers in Patients with Heart Failure.
Nochioka K; Sakata Y; Shimokawa H
Adv Exp Med Biol; 2018; 1067():17-30. PubMed ID: 29542073
[TBL] [Abstract][Full Text] [Related]
14. Advances in the treatment of heart failure with a preserved ejection fraction.
Das A; Abraham S; Deswal A
Curr Opin Cardiol; 2008 May; 23(3):233-40. PubMed ID: 18382212
[TBL] [Abstract][Full Text] [Related]
15. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.
van Heerebeek L; Hamdani N; Falcão-Pires I; Leite-Moreira AF; Begieneman MP; Bronzwaer JG; van der Velden J; Stienen GJ; Laarman GJ; Somsen A; Verheugt FW; Niessen HW; Paulus WJ
Circulation; 2012 Aug; 126(7):830-9. PubMed ID: 22806632
[TBL] [Abstract][Full Text] [Related]
16. Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.
Verbrugge FH; Duchenne J; Bertrand PB; Dupont M; Tang WH; Mullens W
Am J Cardiol; 2013 Dec; 112(12):1913-20. PubMed ID: 24286620
[TBL] [Abstract][Full Text] [Related]
17. Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction.
Tannenbaum S; Sayer GT
Curr Opin Cardiol; 2015 May; 30(3):250-8. PubMed ID: 25807227
[TBL] [Abstract][Full Text] [Related]
18. The treatment of heart failure with preserved ejection fraction ("diastolic heart failure").
Hogg K; McMurray J
Heart Fail Rev; 2006 Jun; 11(2):141-6. PubMed ID: 16937033
[TBL] [Abstract][Full Text] [Related]
19. Heart failure with normal left ventricular ejection fraction: what is the evidence?
Kindermann M; Reil JC; Pieske B; van Veldhuisen DJ; Böhm M
Trends Cardiovasc Med; 2008 Nov; 18(8):280-92. PubMed ID: 19345315
[TBL] [Abstract][Full Text] [Related]
20. Heart failure with preserved ejection fraction: current understanding and emerging concepts.
Liu Y; Haddad T; Dwivedi G
Curr Opin Cardiol; 2013 Mar; 28(2):187-96. PubMed ID: 23274284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
